These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1300270)

  • 1. [Influence of protein-restricted diet on motor response fluctuations in Parkinson's disease].
    Hirata H; Asanuma M; Kondo Y; Ogawa N
    Rinsho Shinkeigaku; 1992 Sep; 32(9):973-8. PubMed ID: 1300270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary method for reducing fluctuations in Parkinson's disease.
    Pincus JH; Barry KM
    Yale J Biol Med; 1987; 60(2):133-7. PubMed ID: 3577210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a controlled low-protein diet on the pharmacological response to levodopa and on the plasma levels of L-dopa and amino acids in patients with Parkinson's disease].
    Sanchís G; Mena MA; Martín del Río R; Morales B; Casarejo MJ; de Yébenes MJ; Tabernero C; Jiménez A; de Yébenes JG
    Arch Neurobiol (Madr); 1991; 54(6):296-302. PubMed ID: 1811460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease.
    Barichella M; Marczewska A; De Notaris R; Vairo A; Baldo C; Mauri A; Savardi C; Pezzoli G
    Mov Disord; 2006 Oct; 21(10):1682-7. PubMed ID: 16773618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of an electronic armband in motor function monitoring in patients with Parkinson's disease.
    Cereda E; Pezzoli G; Barichella M
    Nutrition; 2010 Feb; 26(2):240-2. PubMed ID: 19804956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proposal for a protein redistribution diet in the control of motor fluctuations in Parkinson's disease: acceptance and efficacy].
    Giménez-Roldán S; Mateo D; García Almansa A; García Peris P
    Neurologia; 1991 Jan; 6(1):3-9. PubMed ID: 1863456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease.
    McColl CD; Reardon KA; Shiff M; Kempster PA
    Mov Disord; 2002 Nov; 17(6):1227-34. PubMed ID: 12465061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
    Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN
    Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of motor fluctuations in Parkinson's disease.
    Poewe WH
    Neurology; 1994 Jul; 44(7 Suppl 6):S6-9. PubMed ID: 8047260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
    Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variance in effects of subthalamic nucleus stimulation].
    Okiyama R; Yokochi F; Taniguchi M; Takahashi H; Hasegawa N; Hamada I
    No To Shinkei; 2002 Oct; 54(10):883-8. PubMed ID: 12476577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of the motor response to levodopa in Parkinson's disease.
    Clissold BG; McColl CD; Reardon KR; Shiff M; Kempster PA
    Mov Disord; 2006 Dec; 21(12):2116-21. PubMed ID: 17029259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems with long-term levodopa therapy for Parkinson's disease.
    Marsden CD
    Clin Neuropharmacol; 1994; 17 Suppl 2():S32-44. PubMed ID: 9358193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
    Larsen JP; Boas J
    Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of the proteic redistribution diet (PRD) in the antiparkinsonian effect of L-dopa].
    Duarte J; Moreno C; Coria F; Pérez A; Clavería LE
    Neurologia; 1993 Oct; 8(8):248-51. PubMed ID: 8240836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease.
    Mouradian MM; Heuser IJ; Baronti F; Chase TN
    Ann Neurol; 1990 Jan; 27(1):18-23. PubMed ID: 2301923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.